Gentili-L, Capitano B, Rossi F The Institute S. Gallicano, Rome, Italy SUMMARY Clinical evaluations were carried out at baseline and after one, two and three months of treatment. Two patients in the actively treated group and five patients in the placebo group were lost to follow-up. Almost 80% of the actively treated patients showed complete or almost complete cure after the treatment period as shown by clinical and photographical documentation. In addition, a significant improvement of fragile hair and brittleness of nails could be observed. In the placebo group no changes as compared with baseline could be observed after the treatment. Because of geographical reasons the population in Italy is highly exposed to highly intense solar UV-light during long periods of the year. During the last decades tanning has become more popular, as tanned skin has become a status symbol. Especially females expose themselves to strong and damaging solar UV-light. Correctly used sun-screeners reduce the damages caused by UBV-light, but do not protect against UVA-light. Therefore sun-screeners do not prevent damage of collagen and elastic fibres in the dermis. This causes clinical changes such as thinning of the skin, laxity, solar keratosis, dyskeratosis and premalignant and malignant skin tumours. This condition, which is well documented, is called solar elastosis. As the mean age of the population steadily increases has also the incidence of elastosis increased, and there is now an urgent need to find means to prevent or decrease the severity of sun-damage of the skin. During recent years several reports have confirmed that special marine derived substances seem to have a good effect as regards reconstruction of elastosis age-damaged skin (1,2,3). The present study was an evaluation of oral treatment of solar elastosis in females with Vivida. PATIENTS AND METHODS Before the start of the trial all subjects were orally informed about the nature of the study. At the baseline visit and monthly during the study a clinical evaluation of the severity of elastosis including wrinkles, thinning of the skin, laxity, dyskeratosis and eventual epitheliomas were recorded. After the end of the study the opinion regarding the effect of the treatment was also recorded. At each visit a photograph was taken from the same site of the skin using a Skin-Polaphy, Marcor (100 x magnification). RESULTS DISCUSSION During discussions with the females who received active treatment it became definitely clear that all of them were highly satisfied with the result of the treatment and that all of them would have liked to be on the same treatment for a longer period of time. The females in the placebo group were very impressed by the results in the actively treated group and wished to receive the active Vivida tablets. An important fact is that this new treatment against elastosis and wrinkles, e.g. by oral treatment, was found to be very comfortable as compared with topical or surgical treatment. It seems that oral treatment creates a higher enthusiasm and treatment compliance in the subjects treated with active Vivida pills, as the results were surprisingly good and better than expected by the investigators and treatment subjects. Even if the treatment period is rather long, this was not regarded as a negative point, as the treated females had earlier used anti-wrinkle creams for long periods without satisfying result. In further studies we are planning to use ultrasound evaluations in order to get an objective picture of the effect on deeper skin structures. REFERENCES
|